GARDP is a not-for-profit global health organization driven to protect people from the rise and spread of drug-resistant infections, one of the biggest threats to us all. By forging the public and private partnerships that matter, GARDP develops and makes accessible antibiotic treatments for people who need them.
Antibiotic resistance affects everyone
Antibiotic resistance occurs when bacteria change over time and no longer respond to treatment. Approximately every 6 seconds, a life is lost to AMR.

A global crisis of antibiotic resistance
Antibiotic resistance has been identified as one of the top 10 global health threats by the World Health Organization. If left unchecked, antibiotic resistance may make it too risky to carry out routine surgeries and other modern medical interventions. Certain populations, including women and children, suffer disproportionately from this crisis.


GARDP is acting now to counter drug resistance and save lives
GARDP is working to deliver on its “5by2025” initiative and to expand its portfolio with new treatments for bacterial infections that pose the greatest threat to human health.
GARDP’s agreements with pharmaceutical and biotech companies have the potential to slash delays in access to antibiotics from decades to years.
We engage with all key stakeholders from the get-go to coordinate efforts in the antibiotic pipeline to develop an ecosystem of antibiotic R&D and access.